Last Price
5.09
Today's Change
-0.01 (0.19%)
Day's Change
4.75 - 5.24
Trading Volume
87,957
Market Cap
8 Million
Shares Outstanding
1 Million
Avg Volume
1,317,131
Avg Price (50 Days)
3.70
Avg Price (200 Days)
6.78
PE Ratio
-63.62
EPS
-0.08
Earnings Announcement
13-Mar-2025
Previous Close
5.10
Open
5.23
Day's Range
4.75 - 5.24
Year Range
2.124 - 16.08
Trading Volume
87,957
1 Day Change
-0.20%
5 Day Change
1.19%
1 Month Change
49.71%
3 Month Change
122.27%
6 Month Change
-25.58%
Ytd Change
73.72%
1 Year Change
-53.09%
3 Year Change
-96.37%
5 Year Change
-97.12%
10 Year Change
-97.12%
Max Change
-97.12%
No result.
Sector: Healthcare - Healthcare
Industry: Medical - Pharmaceuticals
Description:
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.